Usefulness of P-Wave Dispersion in Standard Twelve-Lead Electrocardiography to Predict Transition from Paroxysmal to Persistent Atrial Fibrillation

American Journal of Cardiology

Volumn 102, Issue 5, 2008, Pages 573-577

  Koide, Yasushi ^a   Yotsukura, Masayuki ^b   Ando, Harunori ^a   Aoki, Syuiti ^a   Suzuki, Takaomi ^a   Sakata, Konomi ^b   Ootomo, Eiiti ^a   Yoshino, Hideaki ^b  

^a Yokufukai Geriatric Hospital   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LEAD;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; P WAVE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; VALIDITY;

ADULT; AGED; ATRIAL FIBRILLATION; CONFIDENCE INTERVALS; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TACHYCARDIA, PAROXYSMAL; TIME FACTORS;

EID: 51749115280     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.04.065     Document Type: Article

References (21)

1. Komatsu T., Nakamura S., Saitou E., Kobayashi T., Kumagai K., and Okumura K. Long-term efficacy of antiarrhythmic drugs in the prevention of paroxysmal atrial fibrillation; significance of suffering period. Jpn J Electrocardiol 1 (2000) 27-32
2. Kannel W.B., Abbott R.D., Savage D.D., and McNamara P.M. Epidemiologic features of chronic atrial fibrillation: the Framingham Study. N Engl J Med 306 (1982) 1018-1022
3. Abe Y., Fukunami M., Yamada T., Ohmori M., Shimonagata T., Kumagai K., Kim J., Sanada S., Hori M., and Hoki N. Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography. Circulation 96 (1997) 2612-2616
4. Petersen P. Thromboembolic complications of atrial fibrillation and their prevention: a review. Am J Cardiol 65 suppl (1990) 24C-28C
5. Dilaveris P.E., Gialafos E.J., Sideris S.K., Theopistou A.M., Andrikopoulos G.K., Kyriakidis M., Gialafos J.E., and Toutouzas P.K. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135 (1998) 733-738
6. Andrikopoulos G.K., Dilaveris P.E., Richter D.J., Gialafos E.J., Synetos A.G., and Gialafos J.E. Increased variance of P wave duration on the electrocardiogram distinguishes patients with idiopathic paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 23 (2000) 1127-1132
7. Monorris Jr. J.J., Estes Jr. H., Whalen R.E., Thompson Jr. H.K., and McIntosh H.D. P-Wave analysis in valvular heart disease. Circulation 29 (1964) 242-252
8. In: Feigenbaum H. (Ed). Echocardiography (1981), Lea & Febiger, Philadelphia
9. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 (1983) 839-843
10. Bland J.M., and Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1 (1986) 307-310
11. Savelleva I., and Camm J. Update on atrial fibrillation: part I. Clin Cardiol 31 (2008) 55-62
12. Takahashi N., Seki A., Imataka K., and Fujii J. Clinical features of paroxysmal atrial fibrillation: an observation of 94 patients. Jpn Heart J 22 (1981) 143-149
13. Kannel W.B., Abbott R.D., Savage D.D., and McNamara P.M. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J 106 (1983) 389-396
14. Rostagno C., Bacci F., Martelli M., Naldoni A., Bertini G., and Gensini G. Clinical course of lone atrial fibrillation since first symptomatic arrhythmic episode. Am J Cardiol 76 (1995) 837-839
15. Kopecky S.L., Gersh B.J., McGoon M.D., Whisnant J.P., Holmes D.R., Ilstrup D.M., and Frye R.L. The natural history of lone atrial fibrillation: a population-based study over three decades. N Engl J Med 317 (1987) 669-674
16. Suttorp M.J., Kingma J.H., Koomen E.M., van't Hof A., Tijssen J.G.P., and Lie K.I.L. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. Am J Cardiol 71 (1993) 710-713
17. Peterson P., and Godtfredsen J. Embolic complications in paroxysmal atrial fibrillation. Stroke 17 (1986) 622-626
18. Wyse D.G., Waldo A.L., DiMarco Domanski M.J., Rosenberg Y., Schron E.B., Kellen J.C., Greene H.L., Mickel M.C., Dalqust J.E., and Corley S.D. A comparison of the rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347 (2002) 1825-1833
19. Ogawa S. Development of evidence-based atrial fibrillation rhythm management. Jpn J Electrocardiol 27 (2007) 663-667
20. Dries D.L., Exner D.V., Gersh B.J., Domanski M.J., Waclawiw M.A., and Stevenson L.W. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol 32 (1998) 695-703
21. Horowitz L.N., Spielman S.R., Greenspan A.M., Mintz G.S., Morganroth J., Brown R., Brady P.M., and Kay F.R. Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy. J Am Coll Cardiol 6 (1985) 1402-1407